Funding Rounds
SciRhom

SciRhom Series A (2024, $68M)

SciRhom

iRhom2 antibodies developer for better treatment of autoimmune diseases.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series A

Raised Amount: $68.25M

Raised Date: 2024-09-01

Investors